418
Views
7
CrossRef citations to date
0
Altmetric
Psychiatry: Original articles

Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR)

, , , , , , & show all
Pages 1279-1289 | Accepted 24 Feb 2014, Published online: 19 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Maju Mathews, Srihari Gopal, Isaac Nuamah, Ludger Hargarter, Adam J Savitz, Edward Kim, Wilson Tan, Bernardo Soares & Christoph U Correll. (2019) Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1365-1379.
Read now
Ryoko Nakagawa, Takashi Ohnishi, Hisanori Kobayashi, Akihide Wakamatsu, Ai Tanimura, Kazuo Morita, Toshio Yamaoka, Hideo Usui, Yoshimasa Ogawa, Akiko Fujino & Kazutake Yoshizawa. (2015) The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 1511-1521.
Read now
Shangli Cai, Huafei Lu, Zhihua Bai, Renrong Wu & Jingping Zhao. (2015) Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment 11, pages 1817-1834.
Read now
Fan Zhang, Tianmei Si, Chiun-Fang Chiou, Anthony WF Harris, Chang Yoon Kim, Padmashree Jahagirdar & Steve Ascher. (2015) Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 657-668.
Read now

Articles from other publishers (3)

Gaia Sampogna, Matteo Di Vincenzo, Luigi Giuliani, Giulia Menculini, Emiliana Mancuso, Eleonora Arsenio, Salvatore Cipolla, Bianca Della Rocca, Vassilis Martiadis, Maria Salvina Signorelli & Andrea Fiorillo. (2023) A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia. Brain Sciences 13:11, pages 1577.
Crossref
Kruti Joshi, Lian Mao, David M. Biondi & Robert Millet. (2018) The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia. BMC Psychiatry 18:1.
Crossref
George Awad, Daisy Ng-Mak, Krithika Rajagopalan, Jay Hsu, Andrei Pikalov & Antony Loebel. (2016) Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia. BMC Psychiatry 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.